Thursday, November 21, 2024

Danaher returns a key business to growth, and we’re raising our stock rating back to buy


In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 

Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.



Source link

Related Articles

Latest Articles